Search
China’s Newly Approved Lung Cancer Early Diagnosis Kit Set for Market Release
2 week ago /
Read about 0 minute
Author：小编
On January 26, the research team at the Hangzhou Institute of Medicine, Chinese Academy of Sciences, secured a Class III medical device registration certificate from the National Medical Products Administration. This certification was granted for their innovative detection kit, which targets thirteen antibodies associated with lung cancer and utilizes flow cytometry fluorescence immunoassay technology. Designed to aid in distinguishing between benign and malignant pulmonary nodules identified via CT scans, this kit holds significant promise for enhancing the early detection rates of lung cancer.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
